[For patients with heart failure with preserved ejection fraction, is empagliflozine effective and safe for preventing cardiovascular mortality and heart failure hospitalization?]

Rev Med Interne. 2021 Nov;42(11):814-815. doi: 10.1016/j.revmed.2021.10.001. Epub 2021 Oct 30.
[Article in French]
No abstract available

Keywords: Empagliflozine; Heart failure with preserved ejection fraction; Insuffisance cardiaque à fraction d’éjection préservée; empagliflozine.

Publication types

  • Letter

MeSH terms

  • Cardiovascular System*
  • Heart Failure* / drug therapy
  • Hospitalization
  • Humans
  • Prognosis
  • Stroke Volume
  • Ventricular Function, Left